Hayder Saeed

6PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyPredictive and prognostic markersHaematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 03, 2026
A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T-Cell Lymphoma.

|Jul 25, 2024
In vitro compatibility of admixture solutions of 5-fluorouracil and khapzory (disodium levofolinate) in a single infusion bag.

Hayder Saeed

|May 13, 2024
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.

Rahul S Bhansali, Fredrik Ellin, Thomas Relander

|Nov 29, 2023
Composite Lymphoma with Follicular Lymphoma Transformation to Clonally Related Epstein-Barr Virus (EBV) Positive Diffuse Large B-Cell Lymphoma and EBV-PositiveClassic Hodgkin Lymphoma.

Christopher B Ryder, Hayder Saeed, Mohammad Hussaini

|Sep 27, 2021
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.

Victor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook

|Jun 22, 2021
Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies.

Nina Shah, Miguel-Angel Perales, Cameron J Turtle

Pageof 1

Frequent Collaborators

2 joint publications

Sonali M Smith

1 joint publications

Nina Shah

1 joint publications

Miguel-Angel Perales

1 joint publications

Cameron J Turtle